Multi‐Targeting Phytochemicals for Alzheimer's Disease
Phytotherapy Research · 2025-03 · 39 (3) · 1453-1483
DOI: 10.1002/ptr.8435 ↗At a glance
Übersichtsarbeit in Phytotherapy Research, published online on 2025-01-15. Written by Radha Shree Bhattacharya and 8 co-authors. Institution: Department of Pharmaceutical Sciences, Hemwati Nandan Bahuguna Garhwal University (A Central University), Srinagar, Uttarakhand, India. Major MEDLINE topics: Alzheimer Disease, Phytochemicals. Cited 17 times so far (Crossref); 251 references.
Topics: Demenz
Abstract (original language)
Alzheimer's disease (AD) is a type of neurodegenerative illness in which β‐amyloid (Aβ) and tau protein accumulate in neurons in the form of tangles. The pathophysiological pathway of AD consists of Aβ‐amyloid peptides, tau proteins, and oxidative stress in neurons and increased neuro‐inflammatory response. Food and Drug Administration in the United States has authorized various drugs for the effective treatment of AD, which include galantamine, rivastigmine, donepezil, memantine, sodium oligomannate, lecanemab, and aducanumab. The major disadvantage of these drugs is that they only provide “symptomatic” relief. They are most effective in the early stages or for mild to moderate cases of the disease, but are not suitable for long‐term use. Besides conventional therapies, phytochemicals have the potential to stop the progression of AD. According to research, the use of potential phytochemicals against AD has gained attention due to their potent anti‐inflammatory, antioxidant, anti‐hyperphosphorylation of the tau protein, metal chelation, and anti‐amyloid properties. This study seeks to provide an up‐to‐date compilation of the most current and promising breakthroughs in AD therapy using phytochemicals. It could be concluded that phytochemicals light serve as an effective therapy for AD. However, more mechanistic investigations are needed to determine the clinical implications of phytochemicals in AD treatment.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pharmaceutical Sciences, Hemwati Nandan Bahuguna Garhwal University (A Central University), Srinagar, Uttarakhand, India.
- Institute of Nano Science and Technology (INST), Mohali, Punjab, India.
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh, India.
- Department of Pharmacology and Toxicology, Facility for Risk Assessment and Intervention Studies, National Institute of Pharmaceutical Education and Research (NIPER), S.A.S Nagar, Punjab, India.
- Faculty of Pharmaceutical Sciences, Himachal Pradesh, India.
- Faculty of Pharmacy, Government Pharmacy College, Seraj, V.P.O. Bagsaid, Mandi, Himachal Pradesh, India.
ORCID profiles: Raghuraj Singh, Rahul Kumar Verma, Jayant Kumar
Cite
APA
Bhattacharya, R. S., Singh, R., Panghal, A., Thakur, A., Singh, L., Verma, R. K., Singh, C., Goyal, M., & Kumar, J. (2025). Multi‐Targeting Phytochemicals for Alzheimer's Disease. Phytotherapy Research, 39(3), 1453-1483. https://doi.org/10.1002/ptr.8435
Vancouver
Bhattacharya RS, Singh R, Panghal A, Thakur A, Singh L, Verma RK, et al. Multi‐Targeting Phytochemicals for Alzheimer's Disease. Phytotherapy Research. 2025;39(3):1453-1483. doi:10.1002/ptr.8435
BibTeX
@article{Bhattacharya2025,
author = {Bhattacharya, Radha Shree and Singh, Raghuraj and Panghal, Archna and Thakur, Ashima and Singh, Lachhman and Verma, Rahul Kumar and Singh, Charan and Goyal, Manoj and Kumar, Jayant},
title = {Multi‐Targeting Phytochemicals for Alzheimer's Disease},
journal = {Phytotherapy Research},
year = {2025},
volume = {39},
number = {3},
pages = {1453--1483},
doi = {10.1002/ptr.8435}
}
EUVIMED